Fourth quarter results 2010
(Thomson Reuters ONE) -
Financial results
Navamedic`s fourth quarter 2010 revenues ended at NOK 15.7 million compared with
NOK 13.8 million in the same period of 2009. The quarter represented an all-time
high in terms of sales for Vitaflo AB. Revenues for the full year came in at NOK
55.1 million compared to NOK 52.6 million in 2009.
EBITDA for the fourth quarter reached NOK -2.0 million, compared to NOK -0.3
million in the same period of 2009. The EBITDA result included non-recurring
items of NOK 0.8 million. In the Generic Business Area NOK 3.0 million in
business development cost and NOK 1.6 million in capitalised investments were
booked.
EBITDA for the year ended at NOK -6.5 million compared to NOK -2.5 million in
2009. 2010 full year figures included non-recurring costs of NOK 1.0 million. In
the Generic Business Area NOK 9.3 million in development cost and NOK 1.6
million in capitalised investments were booked.
Net cash derived from operations was NOK -5.2 million in the fourth quarter of
2010, compared to NOK -0.4 million in the fourth quarter of 2009. Net cash from
operations for the full year 2010 was NOK -11.7 million against NOK 0.7 million
the previous year.
Key financial indicators 2010 vs. 2009
+---------------+-----------------+------------------+--------+
| | Group | Group | Group |
+---------------+--------+--------+---------+--------+--------+
| (in NOK '000) | Q4 | Q4 | YTD | YTD | FY |
| | | | | | |
| | 2010 | 2009 | 2010 | 2009 | 2009 |
+---------------+--------+--------+---------+--------+--------+
| Revenues | 15 682 | 13 804 | 55 092 | 52 593 | 52 593 |
+---------------+--------+--------+---------+--------+--------+
| Gross Profit | 6 139 | 4 821 | 22 104 | 20 630 | 20 630 |
| | | | | | |
| Gross margin | 39 % | 35 % | 40 % | 39 % | 39 % |
+---------------+--------+--------+---------+--------+--------+
| EBITDA | -2 005 | -277 | -6 494 | -2 508 | -2 508 |
+---------------+--------+--------+---------+--------+--------+
| EBIT | -5 644 | -2 018 | -15 126 | -9 995 | -9 995 |
+---------------+--------+--------+---------+--------+--------+
Contact:
Bjorn Lindholt, CFO
Tel.: +47 67112542
This information is subject of the disclosure requirements acc. to §5-12
vphl(Norwegian Securities Trading Act)
Navamedic ASA Q4 2010 Presentation:
http://hugin.info/136020/R/1485334/420409.pdf
Navamedic ASA Q4 2010 report:
http://hugin.info/136020/R/1485334/420408.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Navamedic ASA via Thomson Reuters ONE
[HUG#1485334]
Unternehmensinformation / Kurzprofil:
Datum: 03.02.2011 - 23:30 Uhr
Sprache: Deutsch
News-ID 51067
Anzahl Zeichen: 3521
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 135 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Fourth quarter results 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
Navamedic ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
